Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $430.20 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $125.00 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $101.24 | 1 | $0 (2021) |
| Electromed, Inc. | $61.27 | 1 | $0 (2024) |
| Itamar Medical Inc | $47.92 | 1 | $0 (2024) |
| Ardelyx, Inc. | $29.22 | 1 | $0 (2024) |
| Abbott Laboratories | $24.54 | 1 | $0 (2024) |
| Inspire Medical Systems, Inc. | $23.98 | 1 | $0 (2023) |
| Amarin Pharma Inc. | $17.03 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $162.95 | 4 | Electromed, Inc. ($61.27) |
| 2023 | $23.98 | 1 | Inspire Medical Systems, Inc. ($23.98) |
| 2021 | $101.24 | 1 | AstraZeneca Pharmaceuticals LP ($101.24) |
| 2020 | $17.03 | 1 | Amarin Pharma Inc. ($17.03) |
| 2019 | $125.00 | 1 | Eisai Inc. ($125.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $61.27 | General |
| Category: HFCWO | ||||||
| 06/03/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $47.92 | General |
| Category: Sleep Apnea testing | ||||||
| 02/14/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/21/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $101.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/15/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular | ||||||
| 06/09/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 198 | 240 | $95,277 | $18,693 |
| 2022 | 9 | 218 | 244 | $138,127 | $25,752 |
| 2021 | 7 | 117 | 125 | $61,264 | $9,611 |
| 2020 | 4 | 122 | 200 | $26,776 | $13,117 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 73 | $12,545 | $5,726 | 45.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 32 | 33 | $41,283 | $3,095 | 7.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 42 | $5,880 | $2,551 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 21 | $5,040 | $2,391 | 47.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 18 | 19 | $22,629 | $1,717 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 30 | $3,250 | $1,520 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,725 | $1,168 | 42.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,925 | $524.35 | 27.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 14 | 14 | $35,000 | $6,637 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 33 | $5,085 | $2,910 | 57.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 49 | $5,625 | $2,800 | 49.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 28 | 28 | $35,028 | $2,713 | 7.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 29 | 29 | $34,539 | $2,706 | 7.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $2,595 | $1,792 | 69.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,675 | $1,722 | 46.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 20 | $3,760 | $1,619 | 43.1% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 16 | 16 | $9,600 | $1,592 | 16.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 23 | $3,220 | $1,261 | 39.2% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 20 | 20 | $23,820 | $1,907 | 8.0% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 18 | 18 | $22,518 | $1,781 | 7.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $2,970 | $1,654 | 55.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 24 | $2,700 | $1,614 | 59.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,625 | $1,238 | 47.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 17 | $2,380 | $955.74 | 40.2% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Facility | 2021 | 12 | 13 | $4,251 | $462.80 | 10.9% |
About Asad Khan
Asad Khan is a Hospitalist healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1396033403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Asad Khan has received a total of $430.20 in payments from pharmaceutical and medical device companies, with $162.95 received in 2024. These payments were reported across 8 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($430.20).
As a Medicare-enrolled provider, Khan has provided services to 655 Medicare beneficiaries, totaling 809 services with total Medicare billing of $67,174. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Sleep Medicine
- Location Latrobe, PA
- Active Since 07/11/2011
- Last Updated 02/10/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1396033403
Products in Payments
- FARXIGA (Drug) $101.24
- SMARTVEST (Device) $61.27
- WatchPATONE (Device) $47.92
- IBSRELA (Drug) $29.22
- JOT DX (Device) $24.54
- INSPIRE (Device) $23.98
- Vascepa (Drug) $17.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.